TTOO - T2 Biosystems, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
114.01M
Enterprise Value 3
135.71M
Trailing P/E
N/A
Forward P/E 1
-3.12
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
14.53
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
17.30
Enterprise Value/EBITDA 6
-2.84

Trading Information

Stock Price History

Beta (3Y Monthly) 0.77
52-Week Change 3-53.98%
S&P500 52-Week Change 36.81%
52 Week High 36.0900
52 Week Low 30.5200
50-Day Moving Average 32.2315
200-Day Moving Average 32.0139

Share Statistics

Avg Vol (3 month) 32.06M
Avg Vol (10 day) 3385.44k
Shares Outstanding 544.54M
Float 37.4M
% Held by Insiders 115.57%
% Held by Institutions 149.93%
Shares Short (Sep 30, 2019) 44.13M
Short Ratio (Sep 30, 2019) 41.55
Short % of Float (Sep 30, 2019) 412.51%
Short % of Shares Outstanding (Sep 30, 2019) 49.27%
Shares Short (prior month Aug 30, 2019) 45.5M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-638.61%

Management Effectiveness

Return on Assets (ttm)-48.41%
Return on Equity (ttm)-693.15%

Income Statement

Revenue (ttm)7.85M
Revenue Per Share (ttm)0.18
Quarterly Revenue Growth (yoy)-54.10%
Gross Profit (ttm)-19.39M
EBITDA -47.72M
Net Income Avi to Common (ttm)-56.71M
Diluted EPS (ttm)-1.2840
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)28.42M
Total Cash Per Share (mrq)0.64
Total Debt (mrq)50.12M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.58
Book Value Per Share (mrq)-0.35

Cash Flow Statement

Operating Cash Flow (ttm)-41.49M
Levered Free Cash Flow (ttm)-21.91M